Try our beta test site
4115 studies found for:    Open Studies | "Immune System Diseases"
Show Display Options
Rank Status Study
21 Recruiting Long Term Safety of Anifrolumab in Adult Subjects With Active Systemic Lupus Erythematosus
Condition: Active Systemic Lupus Erythematosus
Interventions: Biological: Anifrolumab;   Drug: Placebo
22 Recruiting Study of BEGEDINA® vs "Conventional Treatment" for Treating Steroid-Resistant Acute GvHD
Condition: Graft vs Host Disease
Interventions: Biological: Begelomab;   Biological: Conventional Second-line Treatment
23 Recruiting Efficacy and Tolerability of Entospletinib in Combination With Systemic Corticosteroids as First-Line Therapy in Adults With Chronic Graft Versus Host Disease (cGVHD)
Condition: Chronic Graft Versus Host Disease
Interventions: Drug: Entospletinib;   Drug: Placebo;   Drug: Systemic Corticosteroids
24 Recruiting Women Empowered to Live With Lupus Study
Condition: Lupus Erythematosus, Systemic
Intervention: Behavioral: Chronic Disease Self-Management Program (CDSMP)
25 Recruiting A Study to Evaluate the Safety, Tolerability, and Activity of KD025 in Subjects With Chronic Graft Versus Host Disease
Condition: Graft vs Host Disease
Intervention: Drug: KD025
26 Recruiting Transplantation of Autologous Stem Cells for the Treatment of Type 1 Diabetes Mellitus
Conditions: Diabetes Mellitus Type 1;   Autoimmune Diseases;   Endocrine System Diseases;   Glucose Metabolism Disorders;   Immune System Diseases;   Metabolic Diseases
Intervention: Biological: Stem Cell Transplantation
27 Recruiting Study of CD30 CAR for Relapsed/Refractory CD30+ HL and CD30+ NHL
Conditions: Lymphoma;   Lymphoma, Non-Hodgkin;   Immune System Diseases;   Immunoproliferative Disorders;   Lymphatic Diseases;   Lymphoproliferative Disorders;   Neoplasms;   Neoplasms by Histologic Type
Intervention: Biological: ATLCAR.CD30 cells
28 Recruiting Administration of T Lymphocytes for Prevention of Relapse of Lymphomas
Conditions: Hodgkin Disease;   Lymphoma;   Lymphoma, Non-Hodgkin;   Immune System Diseases;   Immunoproliferative Disorders;   Lymphatic Diseases;   Lymphoproliferative Disorders;   Neoplasms;   Neoplasms by Histologic Type
Intervention: Drug: ATLCAR.CD30 cells
29 Recruiting Detection and Characterization of Infections and Infection Susceptibility
Conditions: Immune Disorders;   Chronic Granulomatous Disease;   Genetic Immunological Deficiencies;   Hyperimmunoglobulin-E Recurrent Infection Syndrome;   Recurrent Infections;   Unknown Immune Deficiency;   GATA2 Deficiency (MonoMAC);   Nontuberculous Mycobacterial Infections;   Hyper IgE (Job s) Syndrome;   Leukocyte Adhesion Deficiency;   Susceptibility to Disseminated Infections;   Primary Immune Deficiency Disease (PIDD)
Intervention:
30 Recruiting A Study Comparing the Quality of Life of Patients in the Treatment of Eczema by Pediatric Generalists and Specialists
Conditions: Eczema;   Dermatitis;   Dermatitis, Atopic;   Genetic Disease, Inborn;   Hypersensitivity;   Hypersensitivity, Immediate;   Immune System Diseases;   Skin Diseases;   Skin Diseases, Eczematous;   Skin Diseases, Genetic
Interventions: Other: Care provided by general pediatrician;   Other: Care provided by pediatric dermatologist
31 Recruiting Extracorporeal Photopheresis Using Theraflex ECP™ for Patients With Refractory Chronic Graft Versus Host Disease (cGVHD)
Condition: Refractory Chronic Graft Versus Host Disease (cGVHD)
Intervention: Device: Photopheresis Theraflex ECP™
32 Recruiting Study of Ixazomib to Prevent Recurrent or Late Acute and Chronic Graft-versus-Host Disease 1-year After Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Hematologic Malignancies
Conditions: Myeloid Hematologic Malignancy;   Lymphoid Hematologic Malignancy
Intervention: Drug: Ixazomib
33 Not yet recruiting Quantitative Sensory Testing in Subjects With Sensitive Skin or Not
Condition: Sensitive Skin
Intervention: Device: Quantitative Sensory Testing
34 Not yet recruiting Potassium Oxalate and Placebo and Post-bleaching Sensitivity
Condition: Medicaments Substances in Therapeutic Use
Interventions: Procedure: Potassium oxalate 5% gel;   Procedure: Placebo gel
35 Not yet recruiting Lactobacillus Plantarum in Preventing Acute Graft Versus Host Disease in Children Undergoing Donor Stem Cell Transplant
Conditions: Childhood Malignant Neoplasm;   Hematopoietic Cell Transplantation Recipient
Interventions: Procedure: Allogeneic Hematopoietic Stem Cell Transplantation;   Other: Laboratory Biomarker Analysis;   Drug: Lactobacillus plantarum strain 299;   Drug: Lactobacillus plantarum strain 299v;   Other: Placebo
36 Recruiting Facilitated Immunoglobulin Administration Registry and Outcomes Study (FIGARO)
Conditions: Primary Immunodeficiency;   Secondary Immune Deficiency
Intervention: Biological: HyQvia
37 Recruiting Effect of BMS-986165 on the Pharmacokinetics of Rosuvastatin
Conditions: Autoimmune Diseases;   Inflammatory Diseases
Interventions: Drug: BMS-986165;   Drug: Rosuvastatin
38 Recruiting A Study About Low Blood Pressure in Patients With Primary Immunodeficiency Disease Treated With Immune Globulin Products
Condition: Primary Immune Deficiency Disorder
Interventions: Biological: Bivigam;   Biological: Other
39 Recruiting Safety and Tolerability of Higher Infusion Parameters of IgPro20 (Hizentra) in Subjects With Primary Immunodeficiency (PID)
Condition: Primary Immunodeficiency
Intervention: Drug: IgPro20
40 Recruiting Gynaecological Disorders in Not-celiac Wheat Sensitivity
Condition: Non-celiac Wheat Sensitivity
Intervention: Other: Gluten free diet

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.